Smoked cannabis can help relieve muscle tightness and pain in people with multiple sclerosis

May 14, 2012

People with multiple sclerosis may find that smoked cannabis provides relief from muscle tightness — spasticity — and pain, although the benefits come with adverse cognitive effects, according to a new study published in CMAJ (Canadian Medical Association Journal).

Many patients with multiple sclerosis suffer from spasticity, an uncomfortable and disabling condition in which the muscles become tight and difficult to control. While there are drugs to relieve spasticity, they can have adverse effects and do not always sufficiently improve the condition in some patients.

Researchers from the University of California, San Diego School of Medicine, conducted a randomized, double-blinded controlled trial with 30 participants to understand whether smoked can have an effect on muscle spasticity in people whose spasticity does not respond well to existing treatment. The average age of participants was 50 years, and 63% were female. More than half of the participants needed walking aids, and 20% used wheelchairs.

Most trials have focused on the effect of oral cannabis rather than smoked cannabis.

Rather than rely on self-reporting by patients regarding their muscle spasticity — a subjective measure — health professionals rated the spasticity of each participant's joints on the modified Ashworth scale, a common objective tool to evaluate intensity of muscle tone. The researchers found that participants in the smoked cannabis group experienced an almost one-third decrease on the Ashworth scale — 2.74 points — from a baseline score of 9.3, meaning spasticity improved, compared with the placebo group. As well, pain scores decreased by about 50%.

"We saw a beneficial effect of smoked cannabis on treatment-resistant spasticity and pain associated with among our participants," writes Dr. Jody Corey-Bloom, Department of Neuroscience, University of California, San Diego, California, with coauthors. "Although generally well-tolerated by our participants, smoking cannabis was accompanied by acute cognitive effects."

Cognitive function was negatively affected in the smoked cannabis group but not with placebo, as measured by the ability to perform an addition test requiring focused attention. These effects were short term.

"Using an objective measure, we saw a beneficial effect of inhaled cannabis on spasticity among patients receiving insufficient relief from traditional treatments," conclude the authors. "Although generally well-tolerated, smoking cannabis had acute cognitive effects. Larger, long-term studies are needed to confirm our findings and determine whether lower doses can result in beneficial effects with less cognitive impact."

More information: Study online: www.cmaj.ca/lookup/doi/10.1503/cmaj.110837

Related Stories

Recommended for you

Brain stimulation may improve cognitive performance in people with schizophrenia

July 24, 2017
Brain stimulation could be used to treat cognitive deficits frequently associated with schizophrenia, according to a new study from King's College London.

New map may lead to drug development for complex brain disorders, researcher says

July 24, 2017
Just as parents are not the root of all their children's problems, a single gene mutation can't be blamed for complex brain disorders like autism, according to a Keck School of Medicine of USC neuroscientist.

Bird songs provide insight into how developing brain forms memories

July 24, 2017
Researchers at the University of Chicago have demonstrated, for the first time, that a key protein complex in the brain is linked to the ability of young animals to learn behavioral patterns from adults.

Working around spinal injuries: Rehabilitation, drug treatment lets rats recover some involuntary movement

July 24, 2017
A new study in rats shows that changes in the brain after spinal cord injury are necessary to restore at least some function to lower limbs. The work was published recently in the journal eLife.

Scientists capture first image of major brain receptor in action

July 24, 2017
Columbia University Medical Center (CUMC) researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, ...

Research identifies new brain death pathway in Alzheimer's disease

July 24, 2017
Alzheimer's disease tragically ravages the brains, memories and ultimately, personalities of its victims. Now affecting 5 million Americans, Alzheimer's disease is the sixth leading cause of death in the U.S., and a cure ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

ormondotvos
not rated yet May 15, 2012
Vaporized cannabidiol-enriched cannabis is what they SHOULD have been testing. Less confusion, since it's the tetrahydrocannabinol (THC) that has the psychotropic effects, plus the effects of the benzenes and carbon monoxide...

Duh. Ideology makes you stupid.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.